Healthcare systems around the globe are facing challenges that affect the entire supply chain. The sector is concerned primarily with two main issues: patient safety and greater supply chain efficiency and accuracy.
The facility to identify things uniquely and accurately is essential, be it a medication, an item of clinical equipment or even a patient. The regulatory landscape continues to evolve globally. New regulations in the EU, the US and elsewhere will have a major direct impact on the healthcare supply chain.
Unique Device Identification (UDI) is a system used to mark and identify medical devices within the healthcare supply chain.
A single, global system of standards is fundamental to enable an efficient and effective implementation of UDI requirements by all healthcare stakeholders worldwide.
UDI in terms of GS1 Standards
Product serialisation, compliance with international drug pedigree requirements and establishing anti-counterfeiting solutions are key priorities for the pharmaceutical industry.
The Falsified Medicines Directive (FMD) took effect on 9th Feb 2019 for all EU member states.
The directive requires the serialisation of patient packs to include a 2D barcode which are then scanned at the point of dispensing for verification purposes.
Solutions and product offerings should be based on Global Standards (this is becoming a feature on tenders).
As Irish healthcare providers start to request GS1 compliance in tenders, learn here about how you can become GS1 compliant.
Return to Introduction